Edaran Berhad’s Strong Earnings: Positive Free Cash Flow and Low Accrual Ratio
Edaran Berhad (KLSE:EDARAN) has recently released its earnings report, generating considerable positive reaction from investors, a response understandably driven by strong headline profits. Beyond the immediate figures, several encouraging factors have emerged, warranting deeper examination. Simultaneously, advancements in artificial intelligence are poised to revolutionize the healthcare sector, with a select group of companies – those with market capitalizations under $10 billion – actively developing solutions ranging from early diagnostics to groundbreaking drug discovery. This presents a unique opportunity for investors to explore these forward-thinking organizations. A detailed analysis of Edaran Berhad’s financial performance reveals key insights into the company’s ability to translate profits into tangible cash flow, specifically through the utilization of the accrual ratio. This ratio, calculated by subtracting free cash flow from profit over a period and then dividing the result by the average operating assets during that same time frame, effectively measures the extent to which a company converts profit into actual cash.
The interpretation of an accrual ratio is crucial for investors. Generally, a negative accrual ratio is considered a positive indicator, signifying that the company’s free cash flow significantly exceeds its reported profit. Conversely, a positive accrual ratio suggests that a company is retaining a considerable portion of its profit, potentially due to accounting practices or delayed investments. For the year concluding September 2025, Edaran Berhad exhibited a compelling accrual ratio of -0.73. This negative value underscores a remarkable situation: the company’s free cash flow substantially surpassed its reported statutory profit. In fact, Edaran Berhad generated a robust free cash flow of RM64 million over the last twelve months, a figure considerably higher than its reported statutory profit of RM4.27 million. This represents a significant improvement compared to the prior corresponding period, when the company had experienced negative free cash flow. This shift indicates a strengthened financial position and improved operational efficiency.
The substantial increase in free cash flow, coupled with a negative accrual ratio, strongly suggests that Edaran Berhad’s underlying earnings potential may be greater than initially reflected in its statutory profit. The company’s ability to effectively convert profits into cash demonstrates a healthier and more dynamic financial operation. Furthermore, the company’s earnings per share (EPS) has risen by 15% over the past twelve months, reinforcing the positive trend. Investors should, however, recognize that this analysis represents a single facet of understanding Edaran Berhad’s potential. A comprehensive evaluation requires considering a broader spectrum of factors, including return on equity, which many investors deem a valuable indicator of a company’s financial health and operational effectiveness. Others prefer to “follow the money,” actively searching for stocks where insiders are making significant purchases.
While this article has focused primarily on the accrual ratio as a key determinant of Edaran Berhad’s financial standing, it’s important to acknowledge that a holistic assessment necessitates a deeper dive. Investors interested in conducting further research should be cognizant of the inherent risks involved. During our investigation, we identified two warning signs concerning Edaran Berhad, and while one did not immediately raise serious concerns, the other warrants careful consideration. For those seeking additional perspectives, we recommend exploring a collection of companies exhibiting high return on equity, available through this curated list, or examining a selection of stocks with notable insider holdings. It’s crucial to remember that this analysis is presented in a general nature and is based on historical data and analyst forecasts, utilizing an unbiased methodology. Our articles are not intended as financial advice and do not constitute a recommendation to buy or sell any stock; they do not account for your individual objectives or financial circumstances. Simply Wall St’s approach is centered on long-term, fundamentals-driven analysis. It’s important to note that our analysis may not always incorporate the most recent, price-sensitive company announcements or qualitative data. Simply Wall St holds no position in any stocks mentioned within this report.
